In the rapidly evolving landscape of biotechnology, the merger of artificial intelligence and drug discovery continues to unlock groundbreaking advances in medical treatments. The latest collaboration between Insilico Medicine and Therasid Bioscience highlights the transformative potential of
In this interview, we are pleased to welcome Ivan Kairatov, a Biopharma expert with deep knowledge of tech and innovation in the industry and extensive experience in research and development, particularly in gene therapy for sensory disorders. Today, Ivan will share insights on the recent positive
Ivan Kairatov is a biopharma expert with extensive knowledge of technology and innovation in the industry. He has significant experience in research and development and is here to discuss recent findings about lung abnormalities in children and adolescents with long COVID. What is long COVID, and
Ivan Kairatov is a Biopharma expert, with profound knowledge in technology and innovation in the medical industry, and extensive experience in research and development. Today, we'll delve into a study from the University of Colorado Anschutz Medical Campus, discussing its significance for
The transformative impact of AI-based algorithms on the health care industry offers both immense potential for improving medical outcomes and significant challenges related to bias and disparities. The unexpected discovery by radiologist Judy Gichoya, M.D., and her team that AI could predict a
Mirum Pharmaceuticals recently made headlines as they secured FDA approval for Ctexli, also known as chenodiol, as the first treatment for cerebrotendinous xanthomatosis (CTX). CTX, a rare genetic lipid storage disease, affects an estimated 3 to 5 individuals per 100,000. This approval came after a
